Y. Zhang

发表

Inducible expression and pharmacology of the human excitatory amino acid transporter 2 subtype of L‐glutamate transporter

J. Dunlop, J. Dunlop, Z. Lou, 1999, British journal of pharmacology.

Chronic olanzapine activates the Stat3 signal transduction pathway and alters expression of components of the 5-HT2A receptor signaling system in rat frontal cortex

G. Battaglia, B. Zemaitaitis, F. García, 2007, Neuropharmacology.

Neuroendocrine Evidence That (S)-2-(Chloro-5-fluoro-indol- l-yl)-1-methylethylamine Fumarate (Ro 60-0175) Is Not a Selective 5-Hydroxytryptamine2C Receptor Agonist

L. D. van de Kar, M. Shankaran, F. García, 2003, Journal of Pharmacology and Experimental Therapeutics.

The A2A adenosine receptor mediates coronary vasodilation.

E. Ongini, A. Monopoli, G. Lozza, 1998, The Journal of pharmacology and experimental therapeutics.

Estrogen treatment increases the levels of regulator of G protein signaling-Z1 in the hypothalamic paraventricular nucleus: possible role in desensitization of 5-hydroxytryptamine1A receptors

S. A. Barker, F. García, G. Carrasco, 2004, Neuroscience.

Effect of amperozide on rat cortical 5-HT2 and striatal and limbic dopamine D2 receptor occupancy: implications for antipsychotic action.

H. Meltzer, C. Stockmeier, Y. Zhang, 1992, European journal of pharmacology.

Characterization of 5-HT1A receptor functional coupling in cells expressing the human 5-HT1A receptor as assessed with the cytosensor microphysiometer.

J. Dunlop, L. Schechter, J Dunlop, 1998, Journal of pharmacological and toxicological methods.

Hypocretin receptor 1 blockade produces bimodal modulation of cocaine-associated mesolimbic dopamine signaling

Z. Brodnik, R. España, J. Shaw, 2017, Psychopharmacology.

Characterization of typical and atypical antipsychotic drugs based on in vivo occupancy of serotonin2 and dopamine2 receptors.

H. Meltzer, P. Thompson, C. Stockmeier, 1993, The Journal of pharmacology and experimental therapeutics.

Destruction of serotonergic nerve terminals prevents fluoxetine-induced desensitization of hypothalamic 5-HT1A receptors

L. D. van de Kar, G. Battaglia, F. García, 2002, Psychopharmacology.

Chronic Fluoxetine Differentially Affects 5-Hydroxytryptamine2A Receptor Signaling in Frontal Cortex, Oxytocin- and Corticotropin-Releasing Factor-Containing Neurons in Rat Paraventricular Nucleus

L. D. van de Kar, G. Battaglia, F. García, 2003, Journal of Pharmacology and Experimental Therapeutics.

Fluoxetine-induced changes in body weight and 5-HT1A receptor-mediated hormone secretion in rats on a tryptophan-deficient diet.

L. D. van de Kar, G. Battaglia, F. García, 2004, American journal of physiology. Regulatory, integrative and comparative physiology.

Agonist-Induced Serotonin 2A Receptor Desensitization in the Rat Frontal Cortex and Hypothalamus

L. D. van de Kar, G. Battaglia, F. García, 2004, Journal of Pharmacology and Experimental Therapeutics.

PYY3-36 infused systemically or directly into the VTA attenuates fentanyl seeking in male rats

H. Schmidt, M. R. Hayes, Y. Zhang, 2023, Neuropharmacology.

1,3-Dipropyl-8-[2-(5,6-epoxy)norbornyl]xanthine, a potent, specific and selective A1 adenosine receptor antagonist in the guinea pig heart and brain and in DDT1MF-2 cells.

D. Dennis, J. Shryock, L. Belardinelli, 1995, The Journal of pharmacology and experimental therapeutics.

Neuroendocrine Evidence That Ro 60-0175 Is Not a Selective 5-HT 2C Receptor Agonist*

M. Shankaran, F. Garcia, L. Kar, 2002 .